PROMIS Neurosciences Inc. 8-K Report: Key Developments on January 3, 2025
Based on the provided XML snippet from the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: PROMIS NEUROSCIENCES INC.
- CIK (Central Index Key): 0001374339
- SEC File Number: 001-41429
- EIN (Employer Identification Number): 98-0647155
- Address: Suite 200, 1920 Yonge Street, Toronto, ON M4S 3E2
- Phone Number: 416-847-6898
- Filing Information:
- Filing Type: 8-K (which is used to report significant events that shareholders should know about)
- Filing Date: January 3, 2025
- Stock Information:
- Type of Shares: Common Shares, no par value per share
- Ticker Symbol: PMN
- Exchange: NASDAQ
- Reporting Period:
- Start Date: January 3, 2025
- End Date: January 3, 2025
Insights:
- This filing indicates a significant event or change that occurred on January 3, 2025, which is pertinent for stakeholders and investors in PROMIS NEUROSCIENCES INC.
- The company is publicly traded on NASDAQ under the ticker PMN, suggesting it is accessible to a broad range of investors.
- The 8-K filing implies that there might be important developments or announcements that could impact the company’s performance or stock price, warranting investor attention.
This information can form the basis for further investigation into the specifics of the 8-K and the implications of the reported event.